Annual Shareholders Equity
$5.29 M
-$5.10 M-49.09%
December 31, 2023
Summary
- As of February 7, 2025, SLRX annual stockholders equity is $5.29 million, with the most recent change of -$5.10 million (-49.09%) on December 31, 2023.
- During the last 3 years, SLRX annual shareholders equity has fallen by -$16.87 million (-76.14%).
- SLRX annual shareholders equity is now -94.26% below its all-time high of $92.19 million, reached on December 31, 2015.
Performance
SLRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$2.92 M
+$549.20 K+23.12%
September 30, 2024
Summary
- As of February 7, 2025, SLRX quarterly stockholders equity is $2.92 million, with the most recent change of +$549.20 thousand (+23.12%) on September 30, 2024.
- Over the past year, SLRX quarterly shareholders equity has dropped by -$724.90 thousand (-19.86%).
- SLRX quarterly shareholders equity is now -97.34% below its all-time high of $110.08 million, reached on March 31, 2015.
Performance
SLRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
SLRX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.1% | -19.9% |
| 3 y3 years | -76.1% | -65.2% |
| 5 y5 years | -43.0% | -65.2% |
SLRX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.3% | at low | -92.5% | +23.1% |
| 5 y | 5-year | -86.3% | at low | -94.0% | +23.1% |
| alltime | all time | -94.3% | +180.9% | -97.3% | +23.1% |
Salarius Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.92 M(+23.1%) |
| Jun 2024 | - | $2.38 M(-34.9%) |
| Mar 2024 | - | $3.65 M(-31.0%) |
| Dec 2023 | $5.29 M(-49.1%) | $5.29 M(-13.1%) |
| Sep 2023 | - | $6.08 M(-27.7%) |
| Jun 2023 | - | $8.41 M(+51.4%) |
| Mar 2023 | - | $5.56 M(-46.5%) |
| Dec 2022 | $10.38 M(-73.2%) | $10.38 M(-37.5%) |
| Sep 2022 | - | $16.61 M(-46.2%) |
| Jun 2022 | - | $30.88 M(-7.6%) |
| Mar 2022 | - | $33.42 M(-13.7%) |
| Dec 2021 | $38.72 M(+74.7%) | $38.72 M(-9.2%) |
| Sep 2021 | - | $42.65 M(-7.0%) |
| Jun 2021 | - | $45.85 M(-6.0%) |
| Mar 2021 | - | $48.78 M(+120.1%) |
| Dec 2020 | $22.16 M(+109.4%) | $22.16 M(+7.5%) |
| Sep 2020 | - | $20.61 M(+22.3%) |
| Jun 2020 | - | $16.86 M(-6.4%) |
| Mar 2020 | - | $18.00 M(+70.1%) |
| Dec 2019 | $10.58 M | $10.58 M(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $9.74 M(+59.6%) |
| Jun 2019 | - | $6.10 M(-16.1%) |
| Mar 2019 | - | $7.27 M(-21.6%) |
| Dec 2018 | $9.28 M(-68.1%) | $9.28 M(-16.0%) |
| Sep 2018 | - | $11.05 M(-17.6%) |
| Jun 2018 | - | $13.41 M(-38.7%) |
| Mar 2018 | - | $21.89 M(-24.8%) |
| Dec 2017 | $29.11 M(-50.9%) | $29.11 M(-19.6%) |
| Sep 2017 | - | $36.18 M(-18.7%) |
| Jun 2017 | - | $44.50 M(-14.8%) |
| Mar 2017 | - | $52.23 M(-12.0%) |
| Dec 2016 | $59.32 M(-35.7%) | $59.32 M(-10.2%) |
| Sep 2016 | - | $66.03 M(-11.7%) |
| Jun 2016 | - | $74.82 M(-11.1%) |
| Mar 2016 | - | $84.17 M(-8.7%) |
| Dec 2015 | $92.19 M(-1510.0%) | $92.19 M(-5.9%) |
| Sep 2015 | - | $98.00 M(-6.4%) |
| Jun 2015 | - | $104.65 M(-4.9%) |
| Mar 2015 | - | $110.08 M(+206.2%) |
| Dec 2014 | -$6.54 M | - |
| Sep 2014 | - | $35.95 M |
FAQ
- What is Salarius Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual shareholders equity year-on-year change?
- What is Salarius Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Salarius Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of SLRX is $5.29 M
What is the all time high annual shareholders equity for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual stockholders equity is $92.19 M
What is Salarius Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, SLRX annual stockholders equity has changed by -$5.10 M (-49.09%)
What is Salarius Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of SLRX is $2.92 M
What is the all time high quarterly shareholders equity for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly stockholders equity is $110.08 M
What is Salarius Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, SLRX quarterly stockholders equity has changed by -$724.90 K (-19.86%)